SOAT1 and neoplasm: In vitro and in vivo studies demonstrated that metformin inhibits the JAK‐STAT pathway, induces apoptosis in JAK2V617F‐positive cell lines and reduces tumor burden and splenomegaly in Jak2V617F knock‐in‐induced mice.